Inactive FSH in Galactosemia
NCT00619333 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2010-01-12
Summary
The aim of the study is to investigate whether inactive FSH plays a role in the development of Premature Ovarian Failure in women with Classic Galactosemia
Conditions
- Galactosemia
- Premature Ovarian Failure
Interventions
- DRUG
-
follitropin and lutropin
follitropin and lutropin
Sponsors & Collaborators
-
The Dutch Galactosemia Society
collaborator OTHER -
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
Estela Rubio-Gozalbo, MD, PhD · Maastricht University Hospital
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-31
- Primary Completion
- 2010-03-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Comprehensive Assessment of Reactions to Pharmacogenetics in Complex Care Patients
NCT07060300 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH
NCT07187193 ·Status: RECRUITING ·Phase: PHASE2
-
Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome
NCT01113385 ·Status: COMPLETED ·Phase: NA
-
Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease
NCT01206673 ·Status: COMPLETED ·Phase: NA
-
Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia
NCT04902781 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Early History of Universal Screening for Metabolic Disorders
NCT00309400 ·Status: COMPLETED
-
Metformin in Children With Fragile X Syndrome
NCT05120505 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Arginine on Classic Galactosemia
NCT03580122 ·Status: COMPLETED ·Phase: PHASE2
-
Glycosylation in Patients With Galactosaemia
NCT02218632 ·Status: COMPLETED ·Phase: NA
-
EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes
NCT01711606 ·Status: TERMINATED
-
Facioscapulohumeral Dystrophy in Children
NCT02625662 ·Status: COMPLETED
-
Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism
NCT05047354 ·Status: RECRUITING
-
Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor
NCT00816478 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Metabolic Modifications in Children With Noonan Syndrome
NCT02383316 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure
NCT04154553 ·Status: RECRUITING
-
Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years)
NCT03500094 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
NCT01675674 ·Status: TERMINATED
-
Pharmacogenetic Determinants Of Treatment Response In Children
NCT00730678 ·Status: RECRUITING
-
Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease
NCT00487630 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease
NCT02995993 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)
NCT01433354 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
PREPL in Health and Disease
NCT02263781 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of RO4917523 in Pediatric Patients With Fragile X Syndrome
NCT01750957 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia
NCT04117711 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
NCT02126995 ·Status: COMPLETED ·Phase: PHASE2